Commercial molecular biosensors will be available in 2021 for biosensing and DNA sequencing applications.
Roswell will have rapid, low cost, mobile detection systems for diverse biomarkers. Enabling powerful, in-the-field pathogen detection, infectious disease monitoring, environmental monitoring, and identification of bio-specimens, species or individuals.
They are on track to delivering the $100, 1-hour Genome for precision medicine. Simple, fast, low cost and with clinical-grade accuracy including phasing, assembly and direct reading of epigenetic data.
Roswell Biotechnology has a four-year IARPA contract to deliver DNA storage. The goal is exabyte data storage. The DNA reading goal is the equivalent of a $10 genome. The $25 million contract is to develop reading of DNA at 10 TB per day which 400 times the currently available technology.